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Purpose: This study evaluated the effectiveness and quality of sleep (QoS) in adult pa-
tients with nocturnal lower urinary tract symptoms (LUTS) including nocturia and noc-
turnal polyuria.
Materials and Methods: A total of 102 patients with nocturia and daytime LUTS were 
enrolled in this study. All patients completed a questionnaire that included the 
International Prostate Symptom Score (IPSS), quality of life score (QoL), overactive 
bladder questionnaire (OABq), and a sleepiness index. The sleepiness index was meas-
ured with the Korean Beck Depression Inventory (K-BDI), Insomnia Severity Index 
(ISI), Epworth Sleepiness Scale (ESS), Berlin Questionnaire (BQ), and the International 
Restless Legs Syndrome Study Group (IRLSSG). Statistical analyses included the 
Student’s t-test and chi-square test. Differences were considered significant at a p-value 
of less than 0.05.
Results: Nocturia during sleep was experienced by 68 (66.7%) out of 102 patients. There 
was no significant association between the nocturia- and the sleep-related scales, but 
with multiple regression analysis for sex and age, the K-BDI score (p=0.05), IPSS score 
(p=0.05), and OABq (p=0.02) were significantly higher in patients who woke up to void 
during sleep. A total of 57 (55.9%) patients diagnosed with overactive bladder with noc-
turia had severe daytime sleepiness on the ESS questionnaire (p=0.019) and more ur-
gency symptoms on the IPSS questionnaire (p=0.007). 
Conclusions: Patients with nocturia had a greater risk of being depressive and felt sleep-
ier during the daytime. LUTS including nocturia and sleep quality closely affected each 
other. Therefore, clinicians should consider patients’ LUTS and sleep problems or QoS 
as well to provide more satisfying outcomes. 
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INTRODUCTION
Lower urinary tract symptoms (LUTS) are known to reduce 
quality of life (QoL). Nocturnal LUTS such as nocturia 
(nocturnal frequency) and nocturnal polyuria disrupt the 
continuity of sleep. This causes poor quality of sleep (QoS), 
which in turn affects daytime activity and overall QoL. 
Nocturia also increases fatigue and doubles the risk of falls 
and injuries at night [1]. Nocturia is common in elderly pop-
ulations, with a 10-24% rate of incidence [2]; the overall in-
cidence in 18-79-year-old males and females is 37% and 
43%, respectively [3].
　Treating nocturia is thought to improve QoL, but recent 
studies have shown that nocturia treatment only lessens 
nighttime voiding frequency, without changing life qual-
ities [4]. The present study investigated the impact of adult 
nocturnal LUTS on the QoS and, vice versa, the impact of 
sleep consistency on LUTS to identify the optimal manage-
ment strategy for patients with nocturia and sleep dis-
orders.Korean J Urol 2010;51:757-762
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TABLE 1. Patients’ characteristics
Total No. of 
patients (%)
Female Male
n 102 58 44
Age (yr) 56.89±14.56 51.98±15.02 63.36±11.13
BMI 23.57±3.45 23.45±3.99 23.76±2.43
Alcohol 42 (41.18) 23 19
Smoking 14 (13.73) 4 10
Caffeine 65 (63.73) 38 27
Comorbidity 40 (39.22) 23 17
Married 85 (83.33) 50 35
Employed 34 (33.33) 16 18
BMI: body mass index, Alcohol: drink more than once per week, 
Caffeine: drink coffee or caffeine contained in tea more than once
per day, Comorbidity: diabetes mellitus, hypertension, cardiac 
disease, pulmonary disease, neurologic disease
MATERIALS AND METHODS
All study protocols were reviewed and approved by the 
Institutional Review Board of the Clinical Research Center 
of the author’s hospital.
　In this prospective, randomized study, 102 adults aged 
23 to 84 years with symptoms of nocturia and daytime 
LUTS were enrolled from January to June 2009. Patient 
history, physical examination, a 3-day frequency volume 
chart, International Prostate Symptom Score (IPSS), qual-
ity-of-life score (QoL), overactive bladder questionnaire 
(OABq), and uroflowmetry with residual urine check by ul-
trasonography were completed for all participants.
　Patients who had been receiving treatment for LUTS for 
more than 3 months and with any type of sleep distur-
bances were enrolled. Patients treated with centrally act-
ing drugs that may have affected LUTS or sleep patterns 
within the previous 1 month were excluded. Patients with 
polyuria due to external causes were also excluded.
　In this study, nocturia was defined as waking to void 
more than once per night. Every patient was asked to com-
plete a 3-day frequency-volume (FV) chart. With the self- 
reported FV chart, each patient was interviewed about his 
or her nighttime voiding habits and sleep patterns or sleep 
quality. According to these results, the patients were divi-
ded into 2 groups: those who woke to void at night (nocturia) 
comprised the ‘true nocturia’ group, and those who un-
necessarily voided as a consequence of having been awak-
ened comprised the ‘pseudo nocturia’ group.
　Overactive bladder was defined as urinary frequency 
and urgency as determined according to International 
Continence Society criteria by history taking of voiding 
symptoms and voiding pattern from a 3-day FV chart [5].
　Sleep disruption was investigated by one medical doctor, 
patient interviews, and sleep-related questionnaires. 
Sleep questionnaires consisted of questions about basic 
demographic data (age, sex, body weight, height, and mar-
riage and employment status), consumption of alcohol, 
smoking, caffeine intake, medical disease (to identify the 
presence of any medications that might affect nighttime 
urine volume), cardiovascular disease, pulmonary disease, 
neurologic disease, and diabetes mellitus.
　Questionnaires for the detection and analysis of sleep 
problems were all translated into Korean; of these, the 
Korean Beck’s Depression Inventory (K-BDI) had been 
previously validated. The questionnaires included the 
Epworth Sleepiness Scale (ESS) for daytime sleepiness 
(significantly severe daytime sleepiness: ESS total score≥
10) [6]; the K-BDI for mood disorder screening (in men, mild 
depression: 16-19, moderate depression: 20-23, severe de-
pression≥24; in women, mild depression: 17-20, moderate 
depression: 21-24, severe depression≥25) [7]; the Berlin 
Questionnaire (BQ) for sleep apnea (high risk group score= 
1, low risk group score=0) [8]; the Insomnia Severity Index 
(ISI) for measuring the intensity of insomnia (normal: 0-7 
points, subthreshold insomnia: 8-14 points, moderate in-
somnia: 15-21 points, severe insomnia:＞22 points,) [9]; 
and the International Restless Legs Syndrome Study 
Group (IRLSSG) for restless leg syndrome (mild: 1-10 
points, moderate: 11-20 points, severe: 21-30 points, very 
severe: 31-40 points) [10].
　All scores from the LUTS and sleep questionnaires were 
collected and analyzed with SAS ver. 8.2 (SAS Institute 
Inc., Cary, NC, USA) to determine the correlation between 
LUTS and sleep-associated QoL by using the Student’s 
t-test, chi-square test, and multiple regression analysis. 
Statistical differences were considered significant at a 
p-value less than 0.05.
RESULTS
The patient cohort included 44 men (43.1%) and 58 women 
(56.9%). The mean age of the patients was 56.89±14.56 
years (men, 63.36±11.13 [24-81] years; women, 51.98±15.02 
[23-84] years). Patients complaining of LUTS included 85 
out of 102 (83.4%) patients. Within the LUTS group, noctu-
ria was present in 28 (27.5%) patients, and overactive blad-
der (OAB) was present in 57 (55.9%) patients.
　The patients’ mean body mass index (BMI) was 23.57± 
3.45 kg/m
2. A total of 74 of the 102 patients (72.5%) regu-
larly consumed caffeine (Table 1). Forty patients (39.22%) 
had comorbidities, including 23 with hypertension, 7 with 
diabetes, 5 with hypertension and diabetes, 2 with angina, 
1 with heart failure, 1 with asthma, and 1 with spinal 
stenosis. Other patient characteristics that may have af-
fected sleep quality or LUTS are shown in Table 1.
　Patients’ mean voiding volume was 213.39±72.86 ml, 
mean maximal flow rate (Qmax) was 18.74±20.08 ml/s, and 
mean postvoid residual urine volume was 27.33±47.61 ml.
　LUTS scores included the mean total IPSS score (14.94± 
8.34) and the mean QoL score (3.99±1.39). Sleep problem 
scores included the mean K-BDI (7.26±3.29), ISI (7.93± 
6.84), ESS (5.69±4.65), and IRLSSG (2.48±5.97). In addi-
tion, the percentage of patients at high risk on the BQ was 
6.9%.Korean J Urol 2010;51:757-762
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TABLE 3. Differences between voiding symptom scores and nocturia
Questions
Nocturia
p-value
True (n=68) Pseudo (n=34)
IPSS
IQ1 (emptying) 2.28±1.89 1.85±1.95 0.29
a
Q2 (frequency) 2.86±1.63 2.42±1.54 0.2
a
Q3 (intermittency) 2.07±1.66 1.79±1.75 0.42
a
Q4 (urgency) 2.19±1.76 1.67±1.67 0.16
a
Q5 (weak stream) 2.81±1.57 1.88±1.82 0.009
a
Q6 (hesitancy) 1.62±1.63 1.33±1.63 0.4
a
Q7 (nocturia) 2.22±1.42 1.73±1.51 0.11
a
Storage symptom (Q2, Q4, Q7) 7.26±3.85 5.82±3.92 0.081
b
Voiding symptom (Q1, Q3, Q5, Q6) 8.78±5.32 6.85±5.57 0.093
b
IPSS total score 16.03±8.12 12.67±8.46 0.056
b
QoL 4.18±1.22 3.66±1.6 0.076
b
OABq
Q1 (daytime frequency) 1.91±1.58 1.48±1.54 0.2
a
Q2 (uncomfortable urge) 1.81±1.47   1.3±1.42 0.1
a
Q3 (sudden urge) 1.24±1.55 0.85±1.35 0.21
a
Q4 (accidental loss of urine)   1.2±1.56   0.7±1.18 0.1
a
Q5 (nighttime urination) 2.62±1.62 1.61±1.6 0.004
a
Q6 (waking up at night for urination) 2.62±1.65 1.73±1.52 0.01
a
Q7 (uncontrollable urge) 1.67±1.64 1.27±1.4 0.23
a
Q8 (urine loss c strong desire to urination) 1.23±1.64 0.76±1.32 0.15
a
OABq total score 14.3±8.72   9.7±8.32 0.013
b
True nocturia: waking up to void at night, False nocturia: unnecessary voiding as a consequence of being awakened, IPSS: International
Prostate Symptom Score, QoL: quality of life score, OABq: Overactive Bladder questionnaire, 
a: chi-square test, 
b: Student’s t-test
TABLE 2. Differences between sleep-related indices and nocturia
Sleep indices
Nocturia
p-value 
True Pseudo 
Total No. of patients
 (n=102)
68 34
　ESS 5.87±5.71 4.97±4.99 0.342
a
　K-BDI 15.41±14.49 10.73±12.67 0.052
b 
　BQ (high-risk n)
c 7 5 0.517
b 
　ISI 7.72±8.05 8.22±9.43 0.734
a 
　IRSSG 2.07±6.0 2.67±4.85 0.783
b 
OAB No. of patients
 (n=50)
38 12
　ESS 6.6±5.81 5.58±2.61 0.019
a
　K-BDI 17.1±14.1 11.67±11 0.122
b
　BQ (high-risk n)
c 3 2 0.619
b
　ISI 6.76±4.64 6.25±6.27 0.473
a
　IRSSG 2.18±5.89 3.33±5.66 1
b
True nocturia: waking up to void at night, False nocturia: un-
necessary voiding as a consequence of being awakened, ESS: 
Epworth Sleepiness Scale, K-BDI: Korean Beck Depression 
Inventory, BQ: Berlin Questionnaire, ISI: Insomnia Severity 
Index, IRLSSG: International Restless Legs Syndrome Study 
Group, 
a: Student’s t-test, 
b: chi-square test, 
c: more than 2 catego-
ries positive in 3 categories defined as high-risk group
　A total of 68 of the 102 patients (66.7%) complained of 
waking up at night to void (true nocturia); however, there 
was no significant correlation between ‘waking up at night 
to void’ and ‘the daytime sleepiness scale’ (Table 2).
　To analyze the correlation between nighttime frequency 
(true nocturia) and other voiding symptom scores, the IPSS 
was divided into the sum of 7 storage and voiding symptom 
scores: (Q2 [frequency], Q4 [urgency], and Q7 [nocturia]) 
and (Q1 [emptying], Q3 [intermittency], Q5 [weak stream], 
and Q6 [hesitancy]) (Table 3). Question number 5 (weak 
stream) showed a statistically significant correlation be-
tween LUTS and the presence of bladder irritation during 
sleep (p=0.009). The QoL score showed no significant corre-
lation (p=0.076) (Table 3).
　The scores for each question and the total OABq score 
were analyzed. Question number 5 (nighttime urination) 
(p=0.004), question number 6 (waking up at night because 
of urination) (p=0.01), and the total OABq score (p=0.013) 
showed a statistically significant correlation (t-test) (Table 
3).
　The K-BDI score was significantly higher in patients who 
woke up to void during sleep (p=0.05). In the true nocturia 
group, the mean total IPSS scores (p=0.05) and the mean 
total OABq scores (p=0.02) were significantly higher after 
adjusting for age and sex by multiple regression analysis 
(Table 4). However, when only OAB patients were ana-
lyzed, there was no significant correlation (Table 4).Korean J Urol 2010;51:757-762
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TABLE 4. Multiple regression analysis adjusted for patients’ age 
and sex
β p-value
Total No. of patients (n=102)
　Sleep indices
　　ESS 0.79 0.4
　　K-BDI 4.72 0.05
　　ISI −0.64 0.66
　Voiding scales
　　Storage sx. 1.4 0.09
　　Voiding sx. 2.07 0.08
　　IPSS total score 3.45 0.05
　　QoL 0.44 0.13
　　OABq total score 4.25 0.02
OAB No. of patients (n=50)
　Sleep indices
　　ESS 0.59 0.76
　　K-BDI 6.64 0.2
　　ISI 1.16 0.58
　Voiding scales
　　Storage sx. 2.07 0.17
　　Voiding sx. 2.38 0.25
　　IPSS total score 4.45 0.18
　　QoL 0.42 0.39
　　OABq total score 5.43 0.14
ESS: Epworth Sleepiness Scale, K-BDI: Korean Beck Depression
Inventory, ISI: Insomnia Severity Index, Storage sx.: sum of IPSS
questions 2, 4, and 7, Voiding sx.: sum of  IPSS questions 1, 3, 5,
and 6, IPSS: International Prostate Symptom Score, QoL: quality
of life score, OABq: Overactive Bladder questionnaire
TABLE 5. Differences between voiding symptom scores and nocturia in OAB patients
Questions
Nocturia
p-value
True (n=38) Pseudo (n=12)
IPSS
Q1 (emptying) 2.58±1.85 1.33±1.78 0.809
a
Q2 (frequency) 2.86±1.63 2.42±1.54 0.269
a
Q3 (intermittency) 2.07±1.66 1.79±1.75 0.903
a
Q4 (urgency) 2.19±1.76 1.67±1.67 0.007
a
Q5 (weak stream) 2.81±1.56 1.88±1.81 0.414
a
Q6 (hesitancy) 1.62±1.63 1.33±1.63 0.622
a
Q7 (nocturia) 2.21±1.42 1.73±1.5 0.341
a
Storage sx. (Q2, Q4, Q7) 8.05±3.3 6.33±4.75 0.237
b
Voiding sx. (Q1, Q3, Q5, Q6) 7.45±5.57 5.83±5.31 0.425
b
IPSS total score 15.5±8.08 12.17±9.41 0.365
b
QoL 4.37±1.01 4.08±1.62 0.592
b
OABq
Q1 (daytime frequency) 1.91±1.58 1.48±1.54 0.471
a
Q2 (uncomfortable urge) 1.81±1.47 1.3±1.42 0.149
a
Q3 (sudden urge) 1.24±1.55 0.85±1.35 0.654
a
Q4 (accidental loss of urine) 1.2±1.56 0.7±1.18 0.728
a
Q5 (nighttime urination) 2.62±1.62 1.61±1.6 0.268
a
Q6 (waking up at night for urination) 2.62±1.65 1.73±1.52 0.223
a
Q7 (uncontrollable urge) 1.67±1.64 1.27±1.4 0.646
a
Q8 (urine loss c strong desire to urination) 1.23±1.64 0.76±1.32 0.345
a
OABq total score 16.7±8.93 12.42±10.34 0.225
b
True nocturia: waking up to void at night, False nocturia: unnecessary voiding as a consequence of being awakened, IPSS: International
Prostate Symptom Score, QoL: quality of life score, OABq: Overactive Bladder questionnaire, 
a: chi-square test, 
b: Student’s t-test
　The correlations between nocturia and various sleep-re-
lated scales were analyzed in patients diagnosed with 
OAB. Patients with OAB with nocturia or nighttime fre-
quency during sleep more frequently reported “severe day-
time sleepiness” on the ESS questionnaire (p=0.019); how-
ever, these patients did not show any significant correla-
tion with other sleep problem scales (Table 2). 
　The correlation between each LUTS questionnaire and 
the presence or absence of voiding during sleep (true or 
pseudo nocturia) was compared and analyzed. In the IPSS 
score, the question regarding urgency (Q4) was significantly 
correlated with patients with true nocturia (p=0.007); how-
ever, there was no significant correlation between nocturia 
and the QoL IPSS score or the OABq scores (Table 5).
DISCUSSION
Over 72% of the elderly wake up more than once during 
sleep to void, and 24% of them are awakened more than 3 
times per night [11,12]. Nocturia diminishes the general 
QoL, QoS, daytime functioning, morbidity, and mortality 
[12]. Nocturia can be associated with numerous urological 
pathologies such as LUTS-benign prostatic hyperplasia 
(BPH), OAB, neurogenic voiding dysfunction, bladder can-
cer, and so on. It can also be associated with nonurological 
diseases and conditions such as congestive heart failure, 
diabetes mellitus, diabetes insipidus, hypoalbuminemia, 
sleep apnea syndrome, multiple sclerosis, depression, Korean J Urol 2010;51:757-762
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chronic pain, pruritus, and inadequate fluid intake [13]. 
Poor QoS due to nocturia results in daytime fatigue, cogni-
tive impairment, mood alterations, increasing disease 
morbidity, poor productivity, and a higher risk of traffic ac-
cidents due to lack of sleep [14].
　Several reports have shown that some types of sleep dis-
orders are associated with LUTS [15-19]. Yoshimura et al 
studied 6,000 patients aged 41-70 years old with a ques-
tionnaire about nocturnal voiding/nocturia and sleep dis-
orders [16]. They concluded that insomnia and obstructive 
sleep apnea syndrome were significantly correlated with 
nighttime voiding. Periodic limbic movement disorder was 
also correlated with bothersome nighttime voiding. In con-
trast, restless leg syndrome was not significantly corre-
lated with nighttime voiding [16]. 
　Clinically, many people suffer with either LUTS or sleep 
problems at night; however, without careful inspection, it 
is not easy to differentiate which one is primary: poor sleep 
quality due to nighttime LUTS or additional, unnecessary 
voiding due to interrupted sleep at night. Although noctu-
ria and nocturnal polyuria are more common in elderly pa-
tients, the aforementioned situations may also occur fre-
quently among younger populations. Our study population 
encompassed a wide age range (from 20s to 80s), because 
patient selection was based on symptomatic nighttime voi-
ding for any reason, even with proper treatment of LUTS.
　Disruptions of the sleep cycle for any reason can reduce 
QoL. Several recent studies have reported a correlation be-
tween LUTS and QoL, supporting the correlation between 
nocturia, sleep disruptions, and QoL [14,15]. Nocturia was 
more strongly correlated, resulting in decreased daytime 
performance and general well-being. 
　There were no significant correlations between patient 
responses on the IPSS or OABq and the presence of noctu-
ria, except for the IPSS urgency question (Q4). We suggest 
that, because our patients were undergoing treatment for 
their LUTS (either OAB or LUTS-BPH), their treatment 
may have affected their responses on the questionnaires.
　We analyzed the data as a whole and with the data from 
OAB patients with or without nocturia excluded and found 
interesting results. In general, QoL and total IPSS and 
OABq symptoms scores were significantly correlated with 
the presence of nocturia, although IPSS, QoL, and total 
score showed borderline significance (IPSS QoL p=0.056; 
IPSS total p=0.076; OABq total p=0.013). However, when 
OAB patients were excluded from the analysis, the scores 
from both LUTS questionnaires showed significant diffe-
rences. These findings support the hypothesis that some 
nocturia patients with low QoL may be affected more by 
masked or ignored sleep problems.
　Scores on IPSS question 7 (Q7, about nocturia) showed 
no difference between the true and pseudo nocturia groups. 
However, this question was based on the patients’ sub-
jective symptoms but did not account for the voiding diary; 
any patient who was suffering from frequent nighttime 
voiding produced a high score.
　Multiple regression analysis showed a significant corre-
lation between true nocturia and K-BDI (p=0.05), IPSS to-
tal score (p=0.02), and OABq total score (p=0.05). These da-
ta support the hypothesis that nocturia is a significant fac-
tor affecting subjective symptom severity and the severity 
of LUTS and daytime sleepiness and that it further affects 
mental health. We can easily presume that depressive peo-
ple lack satisfaction with their QoL.
　Irwin et al reported that the adverse effect of nocturia on 
QoL is related to sleep disorders [17]. Nocturia is the major 
cause of sleep disorders for those over age 50 [18]. Not only 
awakening from sleep to void at night but also the anti-
muscarinics prescribed to treat nocturia, by their action on 
the central nervous system, may disrupt sleep [15,19].
　We investigated the correlation between sleep distur-
bance and nocturia with the ESS for daytime sleepiness, 
K-BDI for mood disorders, BQ for sleep apnea syndrome, 
ISI for insomnia, and IRLSSG for restless leg syndrome. 
In OAB patients, daytime sleepiness was significantly 
more severe with nocturia. Depression scores were sig-
nificantly higher in the LUTS group with true nocturia af-
ter adjustment for age and sex. They also showed sig-
nificantly decreased QoL scores. The daytime sleepiness 
scale was also significantly affected by nocturia.  
　The result of this study support the hypothesis that noc-
turia significantly affects QoL in LUTS patients. Although 
poor sleep quality and sleep disorders might also neg-
atively affect QoL, our group of LUTS patients showed sig-
nificant differences between waking up to void and voiding 
because they were unable to sustain sleep. In other words, 
patients with LUTS combined with bothersome nocturia 
reported more negatively on their daily life or mental 
health than did patients without those symptoms. Some 
patients with simple sleep disruption can be relatively 
easily relived from their sleep problem with proper 
medications. Therefore, if they have concurrent nighttime 
frequency caused by a fragmented sleep pattern, they 
would not consider nocturia as a significant problem after 
proper treatment of the sleep problem.  However, the sce-
nario is different in LUTS with nocturia patients without 
an underlying sleep problem. If their LUTS are not con-
trolled enough even in nighttime, they also have disruption 
in sleep quality, leading to poor general condition and in-
creasing autonomous tone. These would also contribute to 
aggravating LUTS and life quality. Daytime sleepiness 
leads to poor nighttime sleep quality, and daily activities 
become more risky, especially in the elderly population. 
　There are some discrepancies between the whole LUTS 
population and the same population with OAB patients 
excluded. At first, we hypothesized that nocturia as a com-
ponent of OAB might appear as nocturnal frequency with 
decreased nocturnal bladder volume. Therefore, waking 
up often to void will lead to disruption of sleep. Because we 
excluded only patients with nocturnal polyuria from ex-
ternal origins such as heavy drinking and diuretics usage, 
some LUTS patients without OAB might have nocturnal 
polyuria. Because all of the patients were undergoing 
treatment for LUTS for more than 3 months, we think it Korean J Urol 2010;51:757-762
762 Yoo et al
is possible that there was no difference between the true 
and pseudo nocturia groups’ IPSS or OABq scores. Only the 
IPSS urgency score differed significantly between the true 
and pseudo nocturia groups. This is also likely to be the ef-
fect of treatment and the fact that the IPSS questionnaire 
was relatively less specific than the OABq.
　This study clearly had some limitations. The sleep-re-
lated questionnaires (ESS, BQ, ISI, IRLSSG) we used were 
simply translated into Korean without proper validation. 
However, the Korean versions of the questionnaires we 
used are widely being used in the clinical setting.
　This study supports the hypothesis that LUTS, partic-
ularly nocturia, and sleep closely affect each other. 
Clinically, it is common to consider nocturnal frequency as 
the result of sleep disorders or insomnia. In addition, it is 
particularly common among the elderly. However, clini-
cians should be certain to differentiate the main cause of 
poor sleep quality. Tailored management of LUTS and 
sleep disorders that improves the QoS and corrects voiding 
symptoms will provide successful treatment results and 
improve QoL.
CONCLUSIONS
LUTS including nocturia and sleep quality closely affect 
each other. Patients with nocturia had a greater risk of be-
ing depressive and felt sleepier during the daytime. 
Therefore, clinicians should consider their patients’ LUTS 
and sleep problems or QoS as well to provide more satisfy-
ing outcomes.
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